Workshop C – A Deep-Dive into Identification of Inhibitors of TEAD to Bolster your Drug Development Pipeline

Time: 3:00 pm
day: Pre-Conference Workshop Day


TEAD Inhibition remains the key method of targeting the Hippo pathway for targeted

drug development in YAP dependent cancers. Here we will provide pharmacological

insight into potential future drug development candidate inhibitors for TEAD.

Attend this Workshop to:

  • Visualize crystal structures of TEAD binding residues with potential candidate compounds
  • Review the therapeutic opportunities and limitations of TEAD palmitoylation inhibitors in cancers
  • Uncover molecular mechanisms which confer potential therapeutic resistance